COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN THE UNITED STATES (US)

被引：0
|
作者：
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Graham, C. M. [3 ]
Baynton, E. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
[3] Ipsos Healthcare, Boston, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1706
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY8
引用
收藏
页码：A292 / A293
页数：4
相关论文
共 50 条
  • [1] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A522 - A523
  • [2] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN THE UNITED STATES (US)
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A154 - A1555
  • [3] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    Hautamaki, E.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : 374 - 374
  • [4] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A373 - A373
  • [5] DISEASE STATUS, TREATMENTS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS RECEIVING THEIR FIRST BIOLOGIC IN THE UNITED STATES AND EUROPEAN UNION
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A389 - A389
  • [6] Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab
    Ruwaard, J.
    l'Ami, M. J.
    Marsman, A. F.
    Kneepkens, E. L.
    van Denderen, J. C.
    van der Horst-Bruinsma, I. E.
    Nurmohamed, M. T.
    Wolbink, G.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) : 122 - 126
  • [7] Clinically meaningful changes in functional status in patients with ankylosing spondylitis receiving etanercept (Enbrel®) or placebo
    Singh, A
    Wajdula, J
    Fatenejad, S
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S233 - S233
  • [8] Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis
    Kimel, M.
    Revicki, D.
    Rao, S.
    Fryback, D.
    Feeny, D.
    Harnam, N.
    Thompson, C.
    Cifaldi, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 624 - 632
  • [9] Improvements in patient-reported outcomes for subjects with ankylosing spondylitis receiving etanercept therapy
    Davis, JC
    Woolley, JM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 252 - 252
  • [10] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING THEIR FIRST BIOLOGIC IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baskett, A.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A218 - A219
12345